Riley Hospital for Children — Indianapolis, Indiana

Public research footprint of Riley Hospital for Children, compiled from the ClinicalTrials.gov public registry.

664

Registered studies

199

Active

Recruiting now

396

Completed

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · B Acute Lymphoblastic Leukemia · Spindle Cell Rhabdomyosarcoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT07012044 — A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With… (Recruiting)
NCT04166409 — A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With… (Recruiting)
NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Riley Hospital for Children?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.